NDC11 45802006601
This exact 11-digit normalized identifier can correspond to more than one FDA hyphenation. FDA.report preserves the exact identifier and exposes every structurally valid candidate without guessing.
Possible FDA NDC forms#
| Package NDC | Product root |
|---|---|
| 45802-0066-01 | 45802-0066 |
| 45802-0066-1 | 45802-0066 |
| 45802-066-01 | 45802-066 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| AZELASTINE HYDROCHLORIDE AND FLUTICASONE PROPIONATE | AZELASTINE HYDROCHLORIDE, FLUTICASONE PROPIONATE | Padagis Israel Pharmaceuticals Ltd | 625ffdd0-8486-49af-8e77-6aa663be5ac7 | 2025-01-31 | Warnings, Adverse reactions | 45802-066-01 45802-066 45802006601 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.